Current and future trends in biomarker discovery and development of companion diagnostics for arthritis

David Gibson, Michael Bustard, Cathy McGeough, Helena A Murray, Martin A Crockard, Andrew Mc Dowell, Jayne Blayney, Philip Gardiner, AJ Bjourson

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Musculoskeletal diseases such as rheumatoid arthritis are complex multifactorial disorders that are chronic in nature and debilitating for patients. A number of drug families are available to clinicians to manage these disorders but few tests exist to target these to the most responsive patients. As a consequence, drug failure and switching to drugs with alternate modes of action is common. In parallel, a limited number of laboratory tests are available which measure biological indicators or ‘biomarkers’ of disease activity, autoimmune status, or joint damage. There is a growing awareness that assimilating the fields of drug selection and diagnostic tests into ‘companion diagnostics’ could greatly advance disease management and improve outcomes for patients. This review aims to highlight: the current applications of biomarkers in rheumatology with particular focus on companion diagnostics; developments in the fields of proteomics, genomics, microbiomics, imaging and bioinformatics and how integration of these technologies into clinical practice could support therapeutic decisions.
Original languageEnglish
JournalExpert Review of Molecular Diagnostics
Issue number2
Publication statusPublished (in print/issue) - 2015


  • Bioinformatics
  • Companion Diagnostics
  • Genomics ,
  • Microbiomics
  • Stratified Medicine
  • Arthritis


Dive into the research topics of 'Current and future trends in biomarker discovery and development of companion diagnostics for arthritis'. Together they form a unique fingerprint.

Cite this